Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Updated the page’s software/revision version indicator from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-27T07:32:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T02:48:46.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-22T09:08:00.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.2 to v3.4.3 in the page header/footer.
    Difference
    0.1%
    Check dated 2026-03-07T20:41:18.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied, replacing the previous v3.4.1. No substantive study information or user-facing content was changed.
    Difference
    0.1%
    Check dated 2026-02-14T05:05:24.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1, which does not alter the study details, inclusion criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T23:32:17.000Z thumbnail image

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.